GS
Gowri Sankara Rao Perni
About Gowri Sankara Rao Perni
Data last updated:
Gowri Sankara Rao Perni is an Additional Director at Bhanko Pharma Private Limited (since 2021). The companies operate in Pharma. Bhanko Pharma Private Limited reported revenue of ₹6.1 Lakh (FY 2022). Earlier, Gowri Sankara Rao Perni was a Director at Arkoss Life Sciences Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 09 Sep 2021 | 2020 | ₹6.1 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Nov 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Gowri Sankara Rao Perni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anuradha Perni | 09012097 | Bhanko Pharma Private Limited | Director |
| Bhargava Naidu Perni | 09012215 | Bhanko Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gowri Sankara Rao Perni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gowri Sankara Rao Perni
Gowri Sankara Rao Perni currently holds 1 directorship: Bhanko Pharma Private Limited (Additional Director, since 09 Sep 2021, revenue ₹6.1 Lakh (FY 2022)).
Gowri Sankara Rao Perni was first appointed on 09 Sep 2021 as Additional Director at Bhanko Pharma Private Limited.
Gowri Sankara Rao Perni held 1 earlier board appointment: Arkoss Life Sciences Private Limited (Director, from 01 Nov 2021).
The current boards of Gowri Sankara Rao Perni's companies include Anuradha Perni (Bhanko Pharma Private Limited), Bhargava Naidu Perni (Bhanko Pharma Private Limited).